Valuation Trading Multiples & Precedent Transactions: Cardiovascular and Electrophysiology Device Manufacturers
Valuation benchmarks for Cardiovascular and Electrophysiology Device Manufacturers. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.
1.1 - Cardiovascular and Electrophysiology Device Manufacturers Market Context & Valuation Drivers
Companies in this trading comparable group design, manufacture, and market cardiovascular and electrophysiology medical devices used in interventional and surgical procedures. Portfolios span implants and disposable tools with recurring procedure-driven demand. They are grouped as comparables due to similar regulatory pathways, hospital-based sales models, capital and consumable mix, clinical evidence requirements, and margin structures that set valuation benchmarks for public trading comparables in cardiac and vascular care.
Typical capabilities include transcatheter heart valves and surgical valve systems, coronary and peripheral stents, electrophysiology mapping and ablation catheters with navigation software, cardiac rhythm management devices such as pacemakers and defibrillators, vascular access introducers, sheaths, and closure systems, guidewires and delivery platforms for endovascular procedures, hemodynamic monitoring and patient data software, and adjunct minimally invasive surgical tools. Many also offer service, training, and clinical support to drive utilization.
Primary customers include hospital systems, cath labs, and electrophysiology centers, as well as interventional cardiologists and cardiovascular surgeons. Valuation drivers typically include procedure growth, installed-base expansion, recurring disposables revenue, geographic mix, and reimbursement coverage. Investors also track gross margin resilience, R&D productivity and new approvals, operating leverage, and market share within core indications to benchmark performance across public trading comparables.
2. Valuation Analysis: Public Trading Comps & Multiples for Cardiovascular and Electrophysiology Device Manufacturers companies
2.1 - Public Peer Groups & Median Valuation Multiples for Cardiovascular and Electrophysiology Device Manufacturers sector
Comparable group 1: Cardiovascular and Electrophysiology Device Manufacturers
APT Medical
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of electrophysiology and vascular interventional devices dedicated to innovation and development in cardiovascular treatment through a comprehensive portfolio of high-tech medical products
- Key Products:
- EP Catheters: Precise electrophysiology mapping and ablation solutions
- Guidewires: Flexible and durable guidewires for vascular navigation
- Introducer Sheaths: Advanced sheath designs for easier vascular access
- Stents: Customized stent systems for a range of interventional needs
- Neurointervention Devices: Innovative devices for treating neurological conditions
MicroPort EP
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of minimally invasive medical devices focusing on the development, manufacturing, and marketing solutions for cardiac arrhythmia treatment.
- Key Products:
- Navigational Solutions: Devices for cardiac navigation during interventions
- Conventional Solutions: Products for standard medical procedures involving electrophysiology.